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ABSTRACT
Aim To evaluate outcomes of ab interno
trabeculectomy (AIT) with the trabectome following
failed trabeculectomy.
Methods Prospective study of AITs and phaco-AITs
after a failed trabeculectomy. The indication for AIT was
intraocular pressure (IOP) above target on maximally
tolerated therapy, and for phaco-AIT a visually significant
cataract and need to lower IOP or glaucoma
medications. Outcomes included IOP, medications,
complications, secondary procedures and success,
defined as IOP of less than 21 mm Hg and a greater
than 20% reduction from baseline without further
surgery. Exclusion criteria were trabeculectomy less than
3 months prior to AIT or follow-up under 1 year.
Results Seventy-three eyes of 73 patients with 1 year
follow-up were identified. At 1 year, mean IOP in AIT
significantly decreased by 28% from 23.7±5.5 mm Hg,
and medications from 2.8±1.2 to 2±1.3 (n=58). In
phaco-AIT, the mean IOP decreased 19% from 20
±5.9 mm Hg and medications from 2.5±1.5 to 1.6±1.4
(n=15). Transient hypotony occurred in 7%, and further
surgery was necessary in 18%. For AIT and phaco-AIT,
the 1-year cumulative probability of success was 81%
and 87%, respectively.
Conclusions Both AIT and phaco-AIT showed a
reduction in IOP and medication use after 1 year,
suggesting that AIT with or without cataract surgery is a
safe and effective option following failed trabeculectomy.
INTRODUCTION
Trabeculectomy, introduced in the 1960s as an
advancement from full thickness to guarded filtra-
tion, is still often called the standard of glaucoma
surgery because it can achieve an average intraocu-
lar pressure (IOP) of 12.7±5.8 mm Hg at 1 year,1
and an average of 13.5±5.3 mm Hg in repeat tra-
beculectomy.2 It also has the highest complication
rate of all current glaucoma treatment options with
a rate of 39% early and 38% late potentially vision-
threatening events adding up to a cumulative prob-
ability of 77% in a recent randomised controlled
trial3 that is consistent with prior findings of a 78%
cumulative complication rate.4 Performing this pro-
cedure a second time is less effective than the
initial trabeculectomy.5
Ab interno trabeculectomy (AIT) with the trabec-
tome (Neomedix, Inc., Tustin, California) is differ-
ent from cautery because, similar to disruptive or
ablative ophthalmic lasers, this plasma-mediated
ablation uses ionisation and disintegration of tra-
becular meshwork (TM) with highly confined heat
dissipation: histology showed no thermal damage
to adjacent tissues or the outer wall with the excep-
tion of rare coagulation effects at the margins of
the immediate ablation area.6 AIT can lower IOP in
most types of open-angle glaucoma with an intact
downstream drainage system and do so with a
favourable safety profile.7 Since it is performed
through a clear-corneal incision, subsequent filtra-
tion surgery is not affected.8 The efficacy of AIT
following fistulating surgery has not been examined
because it is usually performed in patients with
ocular hypertension or early forms of glaucoma,
while trabeculectomy is deemed appropriate for
more advanced stages. An additional concern was
that AIT after traditional trabeculectomy might be
ineffective because of atrophy after the conven-
tional outflow tract is bypassed.9 Subendothelial
TM deposits and an amorphous material in the jux-
tacanalicular tissue narrowing the lumen were
noted in human eyes following trabeculectomy,
with a significant correlation between lower IOPs
and smaller canals.10 Until now, it was not known
whether Schlemm’s canal and collector sizes may
be too small for AIT to be successful even after
IOP increased again in eyes that had failed filtration
surgery.
The purpose of this study was to evaluate 1-year
outcomes of the few AIT surgeries performed
either alone or combined with phacoemulsification
in patients with a failed trabeculectomy. We
hypothesised, that by removing the diseased mesh-
work and subendothelial plaques, conventional
outflow might be restored to a level that allows
patients to avoid another filtration surgery and, that
removal of more diseased tissue in advanced glau-
comas might result in a more pronounced IOP
response than at early stages.
METHODS
Subjects were enrolled from the Trabectome Study
Group database (previously described)7 11 with data
relating to more than 5000 surgery outcomes, and
divided into patients who had only AITor AITcom-
bined with phacoemulsification (phaco-AIT). AIT is
a plasma surgery ablation technique that uses a
bipolar 550 kHz electrode tip to remove the TM,
the primary resistance to outflow. Approximately
120–180° of nasal TM was ablated.12 13 The main
incisions were made by right-handed surgeons at
220° in right eyes and 20° in left eyes. The same
incision was used in phaco-AIT for both parts of the
procedure. Data for this study was collected with
institutional review board approval, in accordance
with the Declaration of Helsinki and the Health
Insurance Portability and Accountability Act.
This prospective interventional cohort included
all patients with a diagnosis of glaucoma (with or
without visually significant cataract), who had a
failed trabeculectomy at least 3 months prior, and
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had at least 1 year of follow-up. Subjects were excluded if they
had missing preoperative IOP data, end-stage visual field (VF)
damage, or had AIT combined with any other procedure besides
phacoemulsification.
The indication for AIT consisted of IOP above target with
worsening glaucoma on maximally tolerated medical or laser
therapy. The specific target IOP was set on a case-by-case basis
by the individual treating physician as the maximum IOP esti-
mated to prevent further nerve damage. The indication for
phaco-AIT consisted of a visually significant cataract with at least
20/50 on brightness acuity test and the need to lower IOP or
the number of glaucoma medications. VF status of all patients
was categorised as early, moderate, or advanced by individual
glaucoma specialists based on the most recent Humphrey VF
exams (Zeiss, Jena, Germany). When VFs could not be cate-
gorised, for instance, due to non-glaucomatous VF changes, or
unreliable test performance by software assessment, exams were
categorised as ‘other’ not to confound stratification. All patients
had a comprehensive slit lamp and ophthalmoscopy exam prior
to surgery.
We compared IOP measured by Goldmann applanation tono-
metry and the number of glaucoma medications within each
group using the paired t test. A finding of p<0.05 was consid-
ered statistically significant. All visual acuities were converted to
logarithm of the minimum angle of resolution (logMar).
Survival plots were created using Kaplan–Meier survival ana-
lysis. Success was defined as a final IOP of less than 21 mm Hg
and a greater than 20% reduction from baseline without further
surgery. Scattergrams were used to illustrate the proportions of
study subjects who met various criteria for success.
RESULTS
After applying the exclusion criteria, a total of 73 eyes in
73 patients were identified who were treated with AIT after failed
trabeculectomy that were followed for a minimum of 1 year
(figure 1). Baseline patient demographics are presented in table 1.
Figure 2 shows the preoperative and postoperative IOP mea-
surements and change in glaucoma medications over time in
AIT and phaco-AIT, respectively. In the AIT group, the mean
IOP was reduced from 23.7±5.5 to 16.2±3.9 mm Hg (28%
mean reduction, p<0.01) and the number of medications was
reduced from 2.8±1.2 to 2.0±1.3 (p<0.01) at 1 year. In the
phaco-AIT group, the mean IOP was reduced from 20.0±5.9 to
15.6±5.1 mm Hg (19% mean reduction, p=0.11), while the
Figure 1 Trabectome Study Group Database. Cases analysed after
accounting for exclusion criteria (AIT, ab interno trabeculectomy;
phaco-AIT, phacoemulsification cataract surgery combined with AIT;
IOP, intraocular pressure).
Table 1 Baseline patient demographics
AIT
(n=58)
Phaco-AIT
(n=15)
Age
Mean±SD 68±17 71±10
Range 16–90 57–85
Gender, n (%)
Female 28 (48) 7 (47)
Male 28 (48) 8 (53)
NR 2 (3) 0 (0)
Race, n (%)
African–American 3 (5) 0 (0)
Asian 3 (5) 1 (7)
Caucasian 46 (79) 10 (67)
Hispanic 3 (5) 2 (13)
Others 3 (5) 2 (13)
Diagnosis, n (%)
POAG 49 (84) 11 (73)
Pseudoexfoliation glaucoma 4 (7) 2 (13)
Juvenile 1 (2) 0 (0)
CACG 1 (2) 0 (0)
Pigment dispersion 1 (2) 1 (7)
Uveitic glaucoma 1 (2) 1 (7)
Others 1 (2) 0 (0)
Preoperative Snellen acuity, n (%)
logMar (mean±SD) 0.39±0.49 0.51±0.28*
Postoperative Snellen acuity, n (%)
logMar (mean±SD) 0.48±0.71 0.14±0.13
VF, n (%)
Mild 6 (10) 2 (13)
Moderate 14 (24) 2 (13)
Advanced 24 (41) 4 (27)
Others 14 (24) 7 (47)
Disc C/D, n (%)
<0.7 3 (5) 2 (13)
0.7–0.8 17 (29) 5 (33)
>0.8 30 (52) 6 (40)
NR 8 (14) 2 (13)
Shaffer grade, n (%)
I 0 (0) 0 (0)
II 4 (7) 0 (0)
III 8 (14) 6 (40)
IV 31 (53) 4 (27)
NR 15 (26) 5 (33)
*p=0.01.
AIT, ab interno trabeculectomy; logMar, logarithm of the minimum angle of
resolution; VF, visual field.
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mean number of medications was reduced from 2.5±1.5 to 1.6
±1.4 (p=0.24) at 1 year.
Stratifying all cases by VF status (figure 3), subjects with mild
or moderate VF status had a mean baseline IOP of 24.1
±5.3 mm Hg which was reduced to 17.1±4 mm Hg at 1 year
(24% reduction, p<0.01). The mean number of glaucoma medi-
cations was reduced from 2.2±1.2 to 1.8±1.2 at 1 year (p=1.0).
Patients with advanced VF status had a mean baseline IOP of
22.9±5 mm Hg which was reduced to 15±4.3 mm Hg at 1 year
(31% reduction, p<0.01). The mean number of glaucoma medi-
cations was reduced from 3±1.2 to 2±1.4 at 1 year (p=0.04).
Figure 4 shows the survival plots for AIT and phaco-AIT. For
AIT and phaco-AIT, the 1-year cumulative probability of success
was 81% and 87%, respectively. Table 2 presents success pro-
portions by various success criteria, and figure 5 shows scatter-
grams that allow for visualisation of individual outcomes at
12 months that are captured by those criteria.
Table 3 presents secondary procedures and complications. A
total of 13 cases (18%) went on to require further glaucoma
surgery within 1 year. Five subjects (7%) had transient hypotony
(IOP<5), but in all these cases, the hypotony spontaneously
resolved and there was no loss of vision. There were no
reported cases of aqueous misdirection, infection, wound leaks,
choroidal effusion, or suprachoroidal haemorrhage.
DISCUSSION
Trabeculectomy has long been considered the standard for surgi-
cal treatment of glaucoma. Recently, epibulbar glaucoma drain-
age devices have been shown to be similarly effective.3
In this study, we evaluated for the first time the outcomes of
AIT and phaco-AIT in subjects with glaucoma who had previ-
ously failed trabeculectomy. Such minimally invasive glaucoma
procedures had been hypothesised to be ineffective after
outflow tract bypassing surgery, and generally thought to be less
effective than traditional glaucoma drainage procedures. We
found that after 1 year, AIT performed alone showed a statistic-
ally significant decrease in IOP and in the number of glaucoma
medications, while phaco-AIT resulted in a similar trend but did
not reach statistical significance for medications (given differ-
ence of means and SD observed, the sample size would have to
be at least 20). Furthermore, the effect was similar when strati-
fied by VF status. Our results suggest that AIT may offer an
attractive therapeutic option for patients who require further
IOP lowering after failed glaucoma surgery, and especially in
those who are unwilling or unable to tolerate repeat traditional
glaucoma surgery.
In this study, the mean IOP decreased by 28% from a baseline
of 23.7 mm Hg after AIT, and by 19% from a baseline of
Figure 2 Preoperative and postoperative intraocular pressure (IOP) measurements (top) and change in glaucoma medications (bottom) over time in
ab interno trabeculectomy (AIT) (left) and phaco-AIT (right).
Figure 3 Relative decrease of intraocular pressure (IOP) (top) and
number of topical glaucoma medications (bottom graph) in patients
with mild to moderate (gray) and advanced (black). Patients with
advanced visual field loss had a larger IOP decrease on average.
Bottom: table with means and SDs (all p>0.05).
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20 mm Hg after phaco-AIT, which matches previous reports that
also report a higher baseline IOP in the AIT group.14 15 In
common with those studies, and reflecting different indications,
IOP reduction was greater in AIT alone compared with the
phaco-AIT group. Francis and colleagues reported a 1-year
phaco-AIT case series of 304 subjects with an overall success
rate of 64%, defining success as ≥20% drop in IOP, or a
decrease in glaucoma medications without the need for addit-
ional medications or glaucoma procedures, including laser trabe-
culoplasty.15 Olali reported an 82% success (defined as
IOP≤21 mm Hg) 1 year after a repeat trabeculectomy with
mitomycin-C following a failed trabeculectomy.2 In our study,
89% of AIT and 92% of phaco-AIT patients had an IOP below
21 mm Hg at 12 months. Although surgical successes cannot be
compared directly, it is possible that patients who are phenotyp-
ically more likely to fail trabeculectomy due to fibrosis will fail
the same procedure again from the same cause, while fibrosis
may not play a primary role in ab interno trabeculectomy.
When conventional outflow is decreased following trabecu-
lectomy,9 the TM develops subendothelial deposits.10 The find-
ings reported here suggest that the distal outflow tract does not
irreversibly atrophy, and that natural outflow can be restored.
When stratifying results by baseline VF status as a surrogate for
glaucoma status, IOP was lower in the group with more
advanced disease, suggesting that removal of a more diseased
outflow resistance can result in a larger decrease in IOP.
Our study had several limitations, including a potential selec-
tion bias towards worse outcomes, as only the initial 20 cases
are required to be submitted to the Trabectome Study Group
Database to obtain full certification followed by subsequent vol-
untary reporting. Though this was a prospective cohort, it is
based on a limited sample size with a relatively short-term
follow-up.
Figure 4 Kaplan–Meier survival plots for ab interno trabeculectomy (AIT) (left) and phacoemulsification cataract surgery combined with AIT
(phaco-AIT) (right) with success defined as a final intraocular pressure of less than 21 mm Hg and a greater than 20% reduction from baseline
without further surgery.
Table 2 Success proportions by various criteria
AIT n (%) Phaco-AIT n (%)
Total number of survived cases 47 13
(1) <21 mm Hg or 20% IOP reduction 44 (94) 12 (92)
(2) <18 mm Hg or 20% IOP reduction 37 (79) 11 (85)
(3) <15 mm Hg or 20% IOP reduction 33 (70) 10 (77)
(4) <12 mm Hg or 20% IOP reduction 31 (66) 8 (62)
(5) 20% IOP reduction 31 (66) 8 (62)
(6) <21 mm Hg 42 (89) 12 (92)
(7) <18 mm Hg 31 (66) 10 (77)
(8) <15 mm Hg 18 (38) 6 (46)
(9) <12 mm Hg 6 (13) 2 (15)
(10) <21 mm Hg and 20% IOP reduction 29 (62) 8 (62)
(11) <18 mm Hg and 20% IOP reduction 25 (53) 7 (54)
(12) <15 mm Hg and 20% IOP reduction 16 (34) 4 (31)
(13) <12 mm Hg and 20% IOP reduction 6 (13) 2 (15)
AIT, ab interno trabeculectomy; IOP, intraocular pressure.
Figure 5 Scattergrams for ab interno trabeculectomy (AIT) (left) and phacoemulsification cataract surgery combined with AIT (phaco-AIT) (right)
demonstrating intraocular pressure (IOP) change from preoperative baseline to final measurement at 12 months.
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In conclusion, AIT can be considered a viable therapeutic
option for patients with a history of previously failed trabecu-
lectomy who require further IOP lowering and are unwilling or
unable to tolerate conventional glaucoma surgery.
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Table 3 Secondary surgeries and postoperative complications
AIT n (%) Phaco-AIT n (%)
Failures requiring further glaucoma surgery
Trabeculectomy 2 (3) 2 (13)
Aqueous shunt 6 (10) 0 (0)
Cyclophotocoagulation 2 (3) 0 (0)
Repeat AIT 1 (2) 0 (0)
Total secondary surgery 11 (19) 2 (13)
Complications
Transient hypotony (IOP<5 mm Hg) 3 (5) 2 (14)
Aqueous misdirection 0 (0) 0 (0)
Infection 0 (0) 0 (0)
Wound leaks 0 (0) 0 (0)
Pain 0 (0) 0 (0)
Choroidal effusion 0 (0) 0 (0)
Choroidal haemorrhage 0 (0) 0 (0)
AIT, ab interno trabeculectomy; IOP, intraocular pressure.
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